7:14 PM Dec 07, 2018

Path to opioid-free pain relief

To jump-start development of analgesics that can help stem the opioid crisis, companies want FDA’s upcoming guidelines to reduce uncertainty around outcomes that constitute clinically meaningful...

6:33 PM Dec 07, 2018

Intermittent move beyond Blincyto

A swath of data at ASH shows that companies have been able to move beyond the 28-day continuous dosing of Amgen Inc.’s first-generation BiTE, Blincyto, to build next-generation antibodies with...

5:21 PM Dec 07, 2018

Novo gets serious about AI-guided drug design

Novo Nordisk A/S is fashioning its R&D makeover to integrate artificial intelligence across its drug discovery and development process, after a pilot program delivered the cost and time...

7:55 PM Dec 06, 2018

Filaments line up as MS biomarker

Neurofilament assays appear on track to become the biomarker of choice for a wide range of neurodegeneration studies, given their tight correlation with axon damage and detectability in blood.

7:31 PM Dec 06, 2018

Germline editing gets technical

As the smoke clears from Jiankui He’s bombshell germline editing announcement, the gap between where the gene editing field is now and where it would need to be to support responsible germline...


Latest News

11:58 AM Dec 13, 2018

U.S., Chinese academies planning meeting to set strict germline gene editing standards

The U.S. National Academy of Sciences, U.S. National Academy of Medicine and Chinese Academy of Sciences...

10:37 AM Dec 13, 2018

Biohaven nets $125M ahead of NDA submissions

Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHNV) raised $125 million late Wednesday through the sale...

9:47 AM Dec 13, 2018

Junshi IPO on deck in Hong Kong as WuXi AppTec shares debut

Shares of WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) were unchanged in their first day of trading...

9:00 AM Dec 13, 2018

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million in an...

5:04 AM Dec 13, 2018

Government shutdown could hobble FDA

Political stalemate in Washington is raising the possibility of a partial government shutdown that could...

5:42 PM Dec 12, 2018

Management tracks: Tamura reclaims CEO role at Sosei

Sosei Group Corp. (Tokyo:4565) said Peter Bains will step down as president and CEO and resign as director...

4:57 PM Dec 12, 2018

BayHelix launches gene-editing task force

Following Chinese researcher Jiankui He's claims he used CRISPR to genetically modify two human embryos,...

4:50 PM Dec 12, 2018

Checkmate raises $22M as Krieg hands off CEO role

Checkmate Pharmaceuticals Inc. (Cambridge, Mass.) said Wednesday it completed a $22 million extension of...

4:41 PM Dec 12, 2018

Contingency planning for U.K. biopharmas to continue after May survives vote

The U.K. life sciences sector avoided further turmoil after a confidence vote in the Conservative party...

4:23 PM Dec 12, 2018

Allen Institute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of...

3:31 PM Dec 12, 2018

Repurposing hypertension drugs to block cytokine release syndrome

Johns Hopkins University School of Medicine researchers showed that hypertension drug Demser metyrosine...

3:31 PM Dec 12, 2018

Tremfya superior to Cosentyx in head-to-head Phase III trial

Janssen Biotech Inc. said Tremfya guselkumab met the primary endpoint of improving PASI 90 response rate...

11:31 AM Dec 12, 2018

Neurocrine down on Phase IIb Tourette syndrome miss

Neurocrine Biosciences Inc. (NASDAQ:NBIX) lost $11.93 (14%) to $73.83 on Wednesday after it said...

10:41 AM Dec 12, 2018

Ra raises $130M on heels of Phase II myasthenia gravis readout

Ra Pharmaceuticals Inc. (NASDAQ:RARX) raised $130 million late Tuesday through the sale of 8.4 million...

10:27 AM Dec 12, 2018

NASH company Akero raises $70M, plans Phase IIa trial

Akero Therapeutics Inc. (San Francisco, Calif.) raised $70 million in a series B round to move non-...

3:30 AM Dec 12, 2018

Lilly, AC Immune to develop tau inhibitors

Eli Lilly and Co. (NYSE:LLY) partnered with AC Immune S.A. (NASDAQ:ACIU) to develop the biotech's pipeline...

4:18 PM Dec 11, 2018

New FDA guidance could spur biomarker-guided clinical trials

FDA released draft guidance on Tuesday providing an evidentiary framework for biomarker qualification,...

4:05 PM Dec 11, 2018

Management tracks: Merck creates new commercial roles to follow Schechter's exit

Merck & Co. Inc. (NYSE:MRK) said President of Global Human Health Adam Schechter will step down at the...

3:52 PM Dec 11, 2018

Anti-CD47 gel prevents cancer recurrence after surgery

ZenCapsule Inc. (Los Angeles, Calif.) is developing a localized sprayable gel similar to an anti-CD47...

3:23 PM Dec 11, 2018

Clock ticking for input on emerging biotech for export controls

Eight days remain for the biotech industry to provide input on how to define emerging technologies as the...

Down Up